Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Regression Models for Categorical and Limited Dependent Variables.
MTW, & Long, J. S. (1997) · Journal of the American Statistical Association · doi:10.2307/2965458 · Cited by 6,898
Regression Models for Categorical and Limited Dependent Variables
Calvin, J. A. (1998) · Technometrics · doi:10.1080/00401706.1998.10485496 · Cited by 5,201
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Gardner, W. P., Mulvey, E. P., & Shaw, E. C. (1995) · Psychological Bulletin · doi:10.1037//0033-2909.118.3.392 · Cited by 1,836
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Cited by
Correlates of Insulin Injection Omission
Peyrot, M., Rubin, R. R., Kruger, D. F., & Travis, L. B. (2010) · Diabetes Care · doi:10.2337/dc09-1348 · Cited by 407
“In another study of patients who switched from using a syringe to deliver insulin to using a pen, 36% of the patients had medication possession rates of 80% while using a syringe, but this rose to 55% after switching to a pen (5).”
BackgroundDavies, M. J., Gagliardino, J. J., Gray, L. J., Khunti, K., Mohan, V., & Hughes, R. (2013) · Diabetic Medicine · doi:10.1111/dme.12128 · Cited by 294
Phillip, M., Bergenstal, R. M., Close, K. L., Danne, T., Garg, S. K., Heinemann, L., Hirsch, I. B., Kovatchev, B. P., Laffel, L. M., Mohan, V., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0375 · Cited by 135
Insulin adherence in patients with diabetes: risk factors for injection omission
Farsaei, S., Radfar, M., Heydari, Z., Abbasi, F., & Qorbani, M. (2014) · Primary care diabetes · doi:10.1016/j.pcd.2014.03.001 · Cited by 106
Guerci, B., Chanan, N., Kaur, S., Jasso-Mosqueda, J. G., & Lew, E. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0590-x · Cited by 106
“These are associated with total mean all-cause treatment costs reductions of 1590 USD per patient per year [61].”
BackgroundClifford, S., Perez-Nieves, M., Skalicky, A. M., Reaney, M., & Coyne, K. S. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.884491 · Cited by 99
Health economics and compliance of vials/syringes versus pen devices: a review of the evidence
Asche, C. V., Shane-McWhorter, L., & Raparla, S. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0180 · Cited by 83
“The studies by Cobden et al. 10 and Lee et al. 11 reported a signifi-cant reduction ( P < 0.05) in hypoglycemic events (odds ratio, 0.40 and 0.50, respectively) and emergency department visits due to hypoglycemic events (odds ratio, 0.36 and 0.44, respectively) for pen devices as opposed to vials =…”
InfluentialA Systematic Review of Insulin Adherence Measures in Patients with Diabetes
Stolpe, S., Kroes, M. A., Webb, N., & Wisniewski, T. (2016) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2016.22.11.1224 · Cited by 77
Brod, M., Rana, A., & Barnett, A. H. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.743458 · Cited by 77
Lasalvia, P., Barahona-Correa, J. E., Romero-Alvernia, D. M., Gil-Tamayo, S., Castañeda-Cardona, C., Bayona, J. G., Triana, J. J., Laserna, A. F., Mejía-Torres, M., Restrepo-Jimenez, P., et al. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816633721 · Cited by 63
“It ranges from 0 to 1, indicating null or complete adherence, respectively.(13,15,23,26) Proportion of days covered (PDC) is calculated in a similar fashion to MPR.”
MethodRandløv, J., & Poulsen, J. U. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200209 · Cited by 61
Liraglutide in clinical practice: dosing, safety and efficacy: Liraglutide in practice
Peterson, G. E., & Pollom, R. D. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02498.x · Cited by 55
Slabaugh, S. L., Bouchard, J. R., Li, Y., Baltz, J. C., Meah, Y. A., & Moretz, D. C. (2015) · Advances in Therapy · doi:10.1007/s12325-015-0266-5 · Cited by 41
Federici, M. O., McQuillan, J., Biricolti, G., Losi, S., Lebrec, J., Richards, C., Miglio, C., & Norrbacka, K. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0396-2 · Cited by 37
Steenkamp, D., Eby, E. L., Gulati, N., & Liao, B. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821997923 · Cited by 33
Adherence to insulin treatment in diabetes: can it be improved?糖尿病患者使用胰岛素治疗的依从性:它能够得到改善吗?
Doggrell, S. A., & Chan, V. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12212 · Cited by 29
Flexibly timed once‐daily dosing with degludec: a new ultra‐long‐acting basal insulin
Josse, R. G., & Woo, V. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12114 · Cited by 24
MacMaster, H. W., Gonzalez, S., Maruoka, A., San Luis, C., Stannard, D., Rushakoff, J. A., & Rushakoff, R. J. (2019) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2018.08.006 · Cited by 12
Piras de Oliveira, C., Mitchell, B. D., Fan, L., Garey, C., Liao, B., Bispham, J., Vint, N., Perez-Nieves, M., Hughes, A., & McAuliffe-Fogarty, A. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1843423 · Cited by 9
Metadata
- Authors
- Lee, W. C., Balu, S., Cobden, D., Joshi, A. V., & Pashos, C. L.
- Venue
- Clinical Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-10
- Volume
- 28
- Issue
- 10
- Pages
- 1712-1725
- ISSN
- 0149-2918 (ISSN-L)
- OpenAlex
- W2036845531
- Cited by
- 266
- References
- 42
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.